#pyrogentestingmarketsize

The APAC region is a highly profitable market for the life sciences industry. For example, India has been taking substantial steps to promote itself as the world's leading major biopharmaceutical innovation hub, including fostering public-private partnerships (PPPs) in biopharmaceutical R&D projects. South Korea is also working to establish itself as a worldwide biotech centre.

North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa make up the global pyrogen testing market. North America held the highest proportion of the worldwide pyrogen testing market in 2019. The high investment on pharmaceutical and biopharmaceutical research, increasing pharmaceutical drug pipelines, a growing number of drug approvals, and increased consumer awareness about product safety are all contributing to the North American pyrogen testing market's growth.